Intravitreal triamcinolone and elevated intraocular pressure

Aust N Z J Ophthalmol. 1999 Dec;27(6):431-2. doi: 10.1046/j.1440-1606.1999.00238.x.


Purpose: To ascertain whether intravitreal triamcinolone given for subretinal neovascularization is associated with an ocular pressure rise.

Methods: A total of 113 patients with angiographically proven subretinal neovascularization were enrolled into a prospective study of the effects of intravitrea triamcinolone. Intraocular pressure was one of the parameters studied.

Results: Approximately 30% of the study group developed a significant rise (> or =5 mm Hg) in intraocular pressure above baseline during the first 3 months.

Conclusions: Patients considering this form of treatment should be fully informed of the known risks of intraocular injections of steroids.

Publication types

  • Comparative Study

MeSH terms

  • Fluorescein Angiography
  • Fundus Oculi
  • Glucocorticoids / adverse effects*
  • Glucocorticoids / therapeutic use
  • Humans
  • Injections
  • Intraocular Pressure / drug effects*
  • Macular Degeneration / complications
  • Ocular Hypertension / chemically induced*
  • Prospective Studies
  • Retinal Neovascularization / drug therapy*
  • Retinal Neovascularization / etiology
  • Risk Factors
  • Treatment Outcome
  • Triamcinolone Acetonide / adverse effects*
  • Triamcinolone Acetonide / therapeutic use
  • Vitreous Body


  • Glucocorticoids
  • Triamcinolone Acetonide